Clinical Trial Update: Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study [Phase 2]

View source ↗

Summary

Open-label extension update for patients treated in the ISD002-P144-07 Phase 2 study led by ISDIN for skin fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Skin Fibrosis

Snippet

Sponsor: ISDIN | Conditions: Skin Fibrosis | Phase 2 | Status: COMPLETED